GLAXOSMITHKLINE FDA Approval ANDA 062691

ANDA 062691

GLAXOSMITHKLINE

FDA Drug Application

Application #062691

Application Sponsors

ANDA 062691GLAXOSMITHKLINE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL0TIMENTINCLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

FDA Submissions

ORIG1AP1986-12-19
LABELING; LabelingSUPPL2AP1991-12-05
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1990-02-26
LABELING; LabelingSUPPL4AP1992-01-30
LABELING; LabelingSUPPL5AP1992-04-17
LABELING; LabelingSUPPL6AP1993-07-16
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-09-16
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1993-09-16
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1994-11-21
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1995-02-23
LABELING; LabelingSUPPL12AP1996-09-13
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1996-07-03
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1996-07-03
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1997-05-02
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1997-10-02
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1997-10-02
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1997-12-29
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1999-02-19
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1999-03-11
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1999-10-25
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2000-01-24
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2001-08-31
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2001-08-31
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2002-02-01
MANUF (CMC); Manufacturing (CMC)SUPPL31AP2002-02-20
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2002-08-13
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2002-12-09
LABELING; LabelingSUPPL42AP2004-02-04
LABELING; LabelingSUPPL45AP2004-10-07
LABELING; LabelingSUPPL46AP2003-10-07
LABELING; LabelingSUPPL47AP2005-07-06
LABELING; LabelingSUPPL49AP2008-06-10
LABELING; LabelingSUPPL50AP2008-06-28
LABELING; LabelingSUPPL51AP2009-02-17
LABELING; LabelingSUPPL52AP2011-03-04
LABELING; LabelingSUPPL53AP2013-06-27
LABELING; LabelingSUPPL54AP2013-06-27

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL33Null0
SUPPL35Null0
SUPPL53Null15
SUPPL54Null15

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62691
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIMENTIN","activeIngredients":"CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","strength":"EQ 100MG BASE\/VIAL;EQ 3GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TIMENTIN","submission":"CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","actionType":"EQ 100MG BASE\/VIAL;EQ 3GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.